Sanara MedTech Inc. (NASDAQ:SMTI) Q3 2023 Earnings Call Transcript

Page 4 of 4

And so that helps us as well. And our most — as we just explained earlier in the call by buying the end, the royalty stream that we were paying out. So that’s where we see how we’re picking up our efficiencies.

Operator: As we currently have no further questions in queue at this time, I will hand it back to Mr. Nixon for his closing comments.

Ron Nixon: Yes. Thank you very much. We appreciate everybody being on the call today. Thank you for all the very good questions that you’ve asked. We’re enthused about where we’re headed with the company. And as I think all of you know, we’re in it for the long term. We want to really build this around our goal of lowering costs and improving outcomes. We want to reach every possible ASC or hospital or any place that we can utilize our proprietary products. And our services as it relates to our post acute. So thank you guys for all the support. We appreciate that, and that will be the end of our call. So thank you all again for being a shareholder of Sanara.

Operator: Thank you, ladies and gentlemen. This concludes today’s conference, and you may disconnect your lines at this time, and we thank you for your participation.

Follow Sanara Medtech Inc. (OTCMKTS:SMTI)

Page 4 of 4